Drug Information Services

The Contract for Drug Information Services is a federal procurement initiative by the Department of National Defence to provide timely, accurate, and evidence-based drug information support to Canadian Forces pharmacists across 33 locations nationwide. Services must be delivered in both English and French, year-round, and are intended to enhance clinical decision-making, policy development, and drug use evaluation by ensuring access to specialized resources and literature reviews grounded in evidence-based medicine. The primary deliverables include structured literature searches, Drug Information Bulletins of 2–4 pages, and training outcomes where pharmacists develop the ability to independently appraise biomedical evidence and respond to complex drug information queries. The solicitation is issued under NAICS code 541690 with the solicitation number W6369-26-A102 and has a closing date of June 23, 2026. The contract includes a base performance period ending March 31, 2027, with three optional one-year extension periods through March 2030, all under the same terms and pricing. Delivery is structured on a Delivery Duty Paid basis, meaning all costs including taxes and duties are included in the offered price, and services must be accessible to personnel at all Canadian Forces health service sites. The evaluation methodology for award is strictly Lowest Price Technically Acceptable, meaning offers must first pass all mandatory technical criteria without exception before pricing is compared among compliant bidders. Required technical qualifications include: a demonstrated company profile with relevant experience, publication of at least five drug information articles using evidence-based methodologies in the past three years, a minimum of twelve months of documented drug information training delivery within the last five years, prior experience delivering drug information services in clinical, policy, or research contexts, and the proposal of two licensed pharmacists each with five or more years of specialized drug information experience and expertise in clinical pharmacology, therapeutics, pharmacovigilance, or medication safety. Offerors must also submit mandatory forms including the Offer Submission Form, Offeror Declaration Form, and certifications regarding employment equity status, supplier nationality, integrity, and compliance with Canada’s Ineligibility and Suspension Policy. Security clearances are required for all personnel, key personnel identified at award must remain assigned unless replaced with approved substitutes subject to government acceptance, and subcontracting requires prior written consent. All submissions must be delivered electronically via CPC Connect, and the government retains full authority to inspect and accept all work, with contractual obligations binding the contractor to adhere to Canadian standards, confidentiality requirements, and